Changes in Bronchiolitis Characteristics During the COVID-19 Pandemic: A Description of Pediatric Emergency Department Visits in a Community Hospital, 2019-2021-Reference-Cited by-同舟云学术

Changes in Bronchiolitis Characteristics During the COVID-19 Pandemic: A Description of Pediatric Emergency Department Visits in a Community Hospital, 2019-2021

Published:2023-10-23 Issue:1 Volume:63 Page:73-79
ISSN:0009-9228
Container-title:Clinical Pediatrics
language:en
Short-container-title:Clin Pediatr (Phila)

Author:

Jurlina, BS Anna¹,Maul Timothy²³^ORCID,Hunsaker, BS Parker¹,Steffen, BS Meagan⁴,Gawaskar, BS Sameep⁴,Sarandria John⁵^ORCID,Glass Todd F.⁶,Blake Kathryn⁷,Alexander Kenneth⁸,Rivera-Sepulveda Andrea⁶^ORCID

Affiliation:

1. College of Medicine, University of Central Florida, Orlando, FL, USA

2. Department of Cardiac Surgery, Nemours Children’s Hospital, Orlando, FL, USA

3. Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA

4. University of Central Florida, Orlando, FL, USA

5. Division of Hospitalist Medicine, Nemours Children’s Health, Orlando, FL, USA

6. Division of Emergency Medicine and Urgent Care, Nemours Children’s Health, Orlando, FL, USA

7. Nemours Children’s Health, Jacksonville, FL, USA

8. Division of Infectious Diseases, Nemours Children’s Hospital, Orlando, FL, USA

Abstract

A retrospective, cross-sectional study of children with bronchiolitis aged 1 to 24 months during an ED visit between 2019 and 2021 was performed. Chi-square or Kruskal-Wallis was used to compare groups. The gamma coefficient was used to measure the association of variables through time. Bronchiolitis cases decreased by 75% from 2019 to 2020 and rose back to prepandemic levels by 2021. Radiographs (gamma −0.443), steroids (gamma −0.298), and bronchodilators (gamma −0.414) decreased during the study period ( P < .001). Laboratory studies (gamma 0.032), viral testing (gamma 0.097), antibiotic use (gamma −0.069), and respiratory support (gamma 0.166) were unchanged. The decrease in steroids and bronchodilators was related to a clinical pathway that discouraged their use. Respiratory support remained unchanged. The COVID-19 pandemic (2019-2021) seems to have had little effect on the severity or resource utilization associated with bronchiolitis but may have unraveled a potential bronchiolitis phenotype that may have been more prominent during the pandemic.

Funder

Agency for Healthcare Research and Quality

Publisher

SAGE Publications

Subject

Pediatrics, Perinatology and Child Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/00099228231208941

Reference31 articles.

1. US Department of Health and Human Services, Centers for Disease Control and Prevention. 2017-2018 estimated flu illnesses, medical visits, hospitalizations, and deaths and estimated flu-related prevented by vaccination in the United States. Date unknown. Accessed July 17, 2023. https://www.cdc.gov/flu/about/burden-averted/2017-2018.htm#table1.